Showing results (11-20 of 500) with videos related to

Sort By:
Pageof 50
Mutagenesis|July 12, 2002
Combined treatment with 4-(N-methyl-N-nitrosamino)-1- (3-pyridyl)-1-butanone and dibutyl phthalate enhances ozone-induced genotoxicity in B6C3F1 miceMin Young Kim, Yong Chul Kim, Myung Haing Cho
Molecules (Basel, Switzerland)|May 1, 2020
Development of UHPLC-MS/MS Method for Indirubin-3'-Oxime Derivative as a Novel FLT3 Inhibitor and Pharmacokinetic Study in RatsNa Yoon Kim, Yong-Chul Kim, Yoon Gyoon Kim
Molecular Neurobiology|June 8, 2004
Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotectionHiroshi Masutani, Jie Bai, Yong-Chul Kim, et al.
Virulence|January 25, 2015
Association of the invasion ability of Porphyromonas gingivalis with the severity of periodontitisKeum Jin Baek, Suk Ji, Yong Chul Kim, et al.
European Journal of Medicinal Chemistry|July 19, 2022
AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonistsKoon Mook Kang, Ingoo Lee, Hojung Nam, et al.
Bioorganic & Medicinal Chemistry|November 8, 2003
Application of a novel design paradigm to generate general nonpeptide combinatorial scaffolds mimicking beta turns: synthesis of ligands for somatostatin receptorsDona Chianelli, Yong-Chul Kim, Dmitriy Lvovskiy, et al.
The Science of the Total Environment|June 20, 2018
Association between extreme temperature and kidney disease in South Korea, 2003-2013: Stratified by sex and age groupsEjin Kim, Ho Kim, Yong Chul Kim, et al.
Anesthesia and Analgesia|September 20, 2013
A comparison of Quincke and Whitacre needles with respect to risk of intravascular uptake in S1 transforaminal epidural steroid injections: a randomized trial of 1376 casesJaehyuck Shin, Yong Chul Kim, Sang Chul Lee, et al.
Drug Development Research|December 7, 2019
A<sub>3</sub> Adenosine Receptors: Protective vs. Damaging Effects Identified Using Novel Agonists and AntagonistsKenneth A Jacobson, Stefano Moro, Yong-Chul Kim, et al.
Plos One|August 27, 2013
Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathyYong-Chul Kim, Ho Jun Chin, Ho Suk Koo, et al.
Pageof 50